Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Jeantils

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Revue Francaise Des Maladies Respiratoires|January 1, 1981
[Legionnaires disease : 3 cases from the northern suburbs of Paris (author's transl)]D Valeyre, E Dournon, V Jeantils, et al.
Annales De Pathologie|January 1, 1996
[Fibrosing cholestatic hepatitis by B virus reactivation in AIDS]B Poulet, F Chapel, P Dény, et al.
Gynecologie, Obstetrique & Fertilite|July 4, 2006
[Efavirenz (Sustiva) in pregnancy: a study about 12 HIV patients]V Jeantils, M-A Khuong, J-L Delassus, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1992
Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosisN Rastogi, B C Ross, B Dwyer, et al.
HIV Medicine|December 12, 2001
Intensification of stable background therapy with abacavir in antiretroviral therapy experienced patients: 48-week data from a randomized, double-blind trialC Katlama, B Clotet, A Plettenberg, et al.
AIDS (London, England)|June 6, 2000
The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial. CNA3002 European Study TeamC Katlama, B Clotet, A Plettenberg, et al.
AIDS (London, England)|June 15, 2000
Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapyD Salmon-Céron, M C Mazeron, S Chaput, et al.
Journal of Virology|February 23, 2000
Phylogenetic analyses indicate an atypical nurse-to-patient transmission of human immunodeficiency virus type 1C P Goujon, V M Schneider, J Grofti, et al.
HIV Medicine|December 8, 2017
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)E Rosenthal, C Fougerou-Leurent, A Renault, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Revue Francaise Des Maladies Respiratoires|January 1, 1981
[Legionnaires disease : 3 cases from the northern suburbs of Paris (author's transl)]D Valeyre, E Dournon, V Jeantils, et al.
Annales De Pathologie|January 1, 1996
[Fibrosing cholestatic hepatitis by B virus reactivation in AIDS]B Poulet, F Chapel, P Dény, et al.
Gynecologie, Obstetrique & Fertilite|July 4, 2006
[Efavirenz (Sustiva) in pregnancy: a study about 12 HIV patients]V Jeantils, M-A Khuong, J-L Delassus, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1992
Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosisN Rastogi, B C Ross, B Dwyer, et al.
HIV Medicine|December 12, 2001
Intensification of stable background therapy with abacavir in antiretroviral therapy experienced patients: 48-week data from a randomized, double-blind trialC Katlama, B Clotet, A Plettenberg, et al.
AIDS (London, England)|June 6, 2000
The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial. CNA3002 European Study TeamC Katlama, B Clotet, A Plettenberg, et al.
AIDS (London, England)|June 15, 2000
Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapyD Salmon-Céron, M C Mazeron, S Chaput, et al.
Journal of Virology|February 23, 2000
Phylogenetic analyses indicate an atypical nurse-to-patient transmission of human immunodeficiency virus type 1C P Goujon, V M Schneider, J Grofti, et al.
HIV Medicine|December 8, 2017
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)E Rosenthal, C Fougerou-Leurent, A Renault, et al.
Pageof 2